United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Pharma Industry News G42 Healthcare begins late-stage trial for Sinopharm COVID-19 vaccine Find out how Sinopharm and G42 Healthcare are advancing the world’s first phase 3 COVID-19 vaccine trial in the UAE. bypharmanewsdailyJuly 20, 2020